Combined Triple Procedure in Retinal Vein Occlusion (RVO)

Sponsor
Johann Wolfgang Goethe University Hospital
Study ID
NCT00805064
Phase
PHASE3
Status
Completed

Conditions

  • Retinal Vein Occlusion

Eligibility Criteria

Sex
ALL
Age
21 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

The aim of this pilot study was to investigate the effects of an intravitreal combination therapy using triamcinolone and bevacizumab in patients with retinal vein occlusion (RVO).

Key Dates

First listed
Dec 9, 2008
Start date
Jan 31, 2006
Status verified
Sep 2012
Primary completion
Dec 31, 2007
Completion
Nov 30, 2008

Study Design

Enrollment
40 participants (actual)
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Active Comparator: ischemic CRVO
    treatment was applied to this entity
  • Active Comparator: non ischemic CRVO
    treatment was applied to this entity
  • Active Comparator: BRVO
    treatment was applied to this entity

Primary Outcome Measure

BCVA [ Time Frame: day of exam ]

Related Studies